Exhibit 99.1

Reporting Person: John Gillard

Issuer: TRINITY BIOTECH PLC

ADDITIONAL HOLDINGS EXHIBIT – CONTINUATION OF TABLE II

Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable
Expiration Date
Title
Amount or Number of Shares
ADS OPTIONS
10/1/2026
12/19/2030
ADS OPTIONS
29,167
$2.40
DIRECT
N/A